Icon
+91 94997 68112
Login Register

Emend - (EQ 150, 115 mg BASE/VIAL; Powder, Intravenous)

Fosaprepitant dimeglumine Merck
EQ 150, 115 mg BASE/VIAL; Powder, Intravenous
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
Less Than 5
More Than 5
More Than 5
Prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of high or moderate emetogenic cancer.
Yes
****** *** ******(*****) **** *** ***** ** **** **** ** **** ******* *******- *** *, ****; *******- *** **, **** *** **** ************ *********. **** ***** ***** *** ****** ** ** ****** ****, ***** **** * ****** ** ****** ** ***** ******* **** ****** '*** ** *****. **** ***** ******** ****** ***** ****** ***** *, ****. **** ***** *********** **** ** *********. ******* **** * **** ****** ****** ******, *** **** ***** **** ** **** ****** '*** *** *** ************ *********.
Emend Patent 1 Patent 2
****** **** ** ** (****** *****) *******
****** (*****) **** ** ** (****** *****) *******
********* **** **** ** ** (****** *****) *** *********
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
****** *** \ ** *** *, **** **** ** ** ******** ******** ** *** **, ****
****** (*****) *** \ ** *** *, **** **** ** ** **** ******** ** *** **, ****
********* **** ** \ ** *** **, **** **** ** ** ******** ***** **** ****
  1. ***** **, **** : ****** *** ******(*****) ******** ***** ***** *** **** ** **** ******* *******- *** *, ****; *******- *** **, ****.
  2. *** **, **** : ***** ***** * **** ******* ****** ** ******** ***** ** **.
  3. *** *, **** : ***** ***** * **** ******* ****** ** ******** ***** ** **.
  4. *** **, **** : ********** ********* **** ****** ** ****** ******* (*** **, ****)
  5. *** **, **** : ********** ********* **** ****** ** ****** ******* (*** **, ****)
  6. *** **, **** : ***** ***** * **** ******* ********* **** ** ****** ******* (***** *, ****)
  7. *** **, **** : ***** ***** **** ****** '*** ** ***** *** ********* ** ****** *** ******
  8. *** **, **** : ***** ***** **** ****** '*** ** ***** *** ********* ** ********* ****
  9. *** **, **** : ***** ***** * **** ******* ****** ** ****** ******* (***** *, ****)
  10. *** **, **** : ***** ***** **** ****** '*** ** ***** *** ********* ** ******
  11. *** **, **** : ***** ***** * **** ******* *** **** ** *** **** ***** **** ** **** ****** '***.
  12. *** **, **** : ***** ***** **** ****** '*** ** ***** *** ********* ** *** ****
  13. *** *, **** : **** ******** *** ** ****** ** *** ******'* ****** **** * ** **** ** "**" ** ****'* ************* *********** *** *********, **. *** ** ****/****

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.